What happens to orgasmic function after surgical benign prostate hypertrophy (BPH) treatments?


Journal

The French journal of urology
ISSN: 2950-3930
Titre abrégé: Fr J Urol
Pays: France
ID NLM: 9918752079106676

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 27 08 2023
revised: 06 11 2023
accepted: 13 11 2023
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 8 5 2024
Statut: ppublish

Résumé

The increasing number of subjects with benign prostate obstruction (BPO) has become a worldwide concern. The sexual problem after benign prostate enlargement (BPE) surgery that has received the most attention in the literature is ejaculation disorder. However, there appears to be a change in orgasmic sensation independent of ejaculation retention. The objective of our study is to explore the influence of BPE surgery on orgasmic function. We evaluated the prospective, multicenter clinical data of 104 patients undergoing BPE surgery who reported maintaining sexual activity from January 2016 to November 2020. The endpoint of this study was to decipher the percentage of patients with an orgasm disorder as assessed by the difference between pre-and-postoperative question 10 of the IIEF 15 questionnaire. Orgasm function was stable, improved, and degraded in 34% (n=35), 30% (n=31), and 36% (n=38) respectively. A deterioration in orgasm was statistically significant in men who maintained quality ejaculation with retained force preoperatively and a high IIEF15 scale values preoperative of orgasmic function, overall and intercourse patient satisfaction. To enable the patient to maintain a satisfying and healthy sex life after any BPE surgery, urologist physicians should know the prevalence of orgasmic side effects after surgical treatment to provide appropriate counseling to patients. Grade 4.

Identifiants

pubmed: 38717458
pii: S2950-3930(24)00004-4
doi: 10.1016/j.fjurol.2024.102570
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

102570

Informations de copyright

Copyright © 2024 Elsevier Masson SAS. All rights reserved.

Auteurs

Etienne Bouchet (E)

Department of urological surgery and andrology, Hospital Center of Brive, Brive-la-Gaillarde, France. Electronic address: etiennebouchet87@gmail.com.

Xavier Orsoni (X)

Department of urological surgery and andrology, Hospital Center of Brive, Brive-la-Gaillarde, France.

Romain Mathieu (R)

Department of Urology, University Hospital Center of Rennes, Rennes, France.

Souhil Lebdai (S)

Department of Urology, University Hospital Center of Angers, Angers, France.

Emmanuel Della Negra (E)

Department of Urology, Hospital center des Côtes d'Armor, Saint Brieuc, France.

Aurelien Descazeaud (A)

Department of urological surgery and andrology, University Hospital Center Dupuytren, Limoges, France.

Gregoire Robert (G)

Department of Urology, University Hospital Center of Bordeaux, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH